Novelion Therapeutics (TSX:NVLN) Purchase Of Investment : C$0.0 Mil (TTM As of Mar. 2019)

View and export this data going back to 1988. Start your Free Trial

What is Novelion Therapeutics Purchase Of Investment?

Novelion Therapeutics's purchase of investment for the three months ended in Mar. 2019 was C$0.0 Mil. It means Novelion Therapeutics spent C$0.0 Mil on purchasing investments. Novelion Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2019 was C$0.0 Mil.

Compared with last quarter (C$0.0 Mil in Dec. 2018 ), Novelion Therapeutics spent the same money on purchasing investments in Mar. 2019 (C$0.0 Mil).

Novelion Therapeutics Purchase Of Investment Historical Data

The historical data trend for Novelion Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novelion Therapeutics Purchase Of Investment Chart

Novelion Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Purchase Of Investment

Get a 7-Day Free Trial

Novelion Therapeutics Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Novelion Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.0 Mil.

Novelion Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Novelion Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Novelion Therapeutics (TSX:NVLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novelion Therapeutics Inc (TSX:NVLN) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Norton Rose Fulbright, 1800 West Georgia Street, Suite 510, Vancouver, BC, CAN, V6B 0M3

Website

http://www.novelion.com

Headquartered in Vancouver, Canada, QLT is a biotechnology company that researches and develops products used to treat conditions of the eye. After a recent board change, QLT divested its only marketed product, a laser treatment called Visudyne for the treatment of wet age-related macular degeneration and subfoveal choroidal neovascularization. QLT also earns royalty payments on other certain previously divested products. Following recent pipeline changes, the company currently has one product in development for two rare eye conditions.

Novelion Therapeutics (TSX:NVLN) Headlines

No Headlines